Sutro Biopharma, a South San Francisco company working to design anti-cancer drugs, is a fresh face for biotech’s extreme ...

A Peninsula biotech company raised $68 million from investors — including a venture philanthropy fund started by Lululemon ...

Late last year, the chief leasing officer for Kilroy Realty Corp. saw more biotech companies showing interest in the second ...

The South San Francisco-based company, which pioneered at-home genetic testing, holds a trove of sensitive genetic data on ...

A Bay Area biotech company is laying off approximately 90 percent of its workforce. According to a press release, Cargo Therapeutics announced the layoffs on Tuesday. The move was ...

But what it does have is its critical role—albeit underrated—as a biotech hub. Competing with South San Francisco and Boston, ...

please reach out to the Fierce Biotech editorial team and let us know. March 21 - Vaxart: The South San Francisco-based company has laid off 10% of its staff after the U.S. government unexpectedly ...

A bankruptcy filing Sunday by 23andMe, a genetic testing and biotechnology company, is shining light on what could happen to ...

(The Center Square) – 23andMe, the prominent San Francisco genetic testing company that helps customers determine their ancestry, has filed for bankruptcy.

The San Francisco-based company said it had profit of 18 cents per share. Losses, adjusted to account for discontinued operations, came to 8 cents per share. The biotech drug developer posted revenue ...

UBS Group AG has hired three investment bankers specializing in biotechnology from RBC Capital Markets as the bank expands ...